-The Hindu Business Line The Government has constituted an Intellectual Property Rights (IPR) think-tank to help draft a new National IPR Policy and to advice it on issues related to intellectual property. The think-tank, headed by Justice Prabha Sridevan, will highlight anomalies in the present IPR legislations and advice the Department of Industrial Policy and Promotion (DIPP) on possible solutions, according to an official release. It will also provide views on the possible...
More »SEARCH RESULT
Total Matching Records found : 501
Reforming the health care sector -Ian D Spatz
-The Hindu Obamacare and other such examples make a compelling case for seeking the right combination of roles for the public and private sector in health reform in India Nail or screw? Which is best to join pieces of wood? In carpentry, the answer is that each offers benefits depending on the application. With health care reform, the choice of public or private sector financing, delivery and regulation is subject to a...
More »Subramanian till recently had opposed India on IPR
-The Times of India The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations. Subramanian...
More »India to soon manufacture health capsule from tea extract -Vanita Srivastava
-The Hindustan Times In what can be a boost for the Make in India slogan the industry and lab are entering into new areas of partnership-latest being transfer of technology from a CSIR lab to make multi nutritional health capsule from tea extracts. CSIR-Institute of Himalayan Bioresource Technology, Palampur in Himachal Pradesh has developed technology for extraction of catechins using water and green solvents without using any hazardous chemicals. The technology...
More »Mala Fide Decision on Drug Prices
-Economic and Political Weekly The decision to reduce the powers of the drug pricing body goes against the interest of public health. The decision of the Government of India to withdraw the power of the National Pharmaceutical Pricing Authority (NPPA) to set price controls on drugs that are not on the National List of Essential Medicines (NLEM) raises questions on the Narendra Modi regime's commitment to people's welfare. One must ask if...
More »
